PACIFIC BIOSCIENCES OF CALIFORNIA, INC.PACB财报
Nasdaq · biotechnology industry
Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.
主要股东
| 股东 | 持股比例 | 股数 | 变动 | 截至 |
|---|---|---|---|---|
| ARK | 12.90% | 34.5M | — | 2024-01-29 |
| BlackRock, Inc. | 9.20% | 24.6M | — | 2024-01-24 |
| Madrone Opportunity Fund, L.P. | 8.60% | 23.4M | ▲ +2.00pp | 2024-11-14 |
| SB Northstar LP | 7.50% | 20.5M | — | 2024-11-26 |
| EDMOND DE ROTHSCHILD ASSET MANAGEMENT | 7.50% | 20.3M | — | 2024-11-14 |
| The Vanguard Group | 6.47% | 17.6M | 无变化 | 2024-11-12 |
| Nikko Asset Management Americas, Inc. | 4.93% | 13.2M | — | 2024-02-12 |
| Sumitomo Mitsui Trust Holdings, Inc. | 4.93% | 13.2M | — | 2024-02-05 |
| Millennium Management LLC | 4.50% | 12.4M | — | 2024-11-08 |
| Jackson Square Partners, LLC | 3.63% | 9.7M | — | 2024-02-09 |
内部人交易
Net 90d: −$1.28M · buys $0 / sells $1.28M时间范围:
类型:
身份:
| 内部人 | 身份 | 类型 | ||||
|---|---|---|---|---|---|---|
| 2026-04-08 | Christopher Gibson | Director | Grant | 57.5K | $0.00 | $0 |
| 2026-04-01 | Gibson James R II | See Remarks | Sell (open market) | 88.2K | $1.37 | $120.8K |
| 2026-03-03 | Christopher Gibson | Director | Grant | 53.9K | $0.00 | $0 |
| 2026-03-03 | HENRY CHRISTIAN O | See Remarks | Sell (open market) | 12.5K | $1.51 | $18.9K |
| 2026-03-03 | Michele Farmer | See Remarks | Sell (open market) | 3.0K | $1.51 | $4.5K |
| 2026-03-03 | Van Oene Mark | See Remarks | Sell (open market) | 6.5K | $1.51 | $9.8K |
| 2026-02-27 | Michele Farmer | See Remarks | Grant | 89.8K | $0.00 | $0 |
| 2026-02-27 | Van Oene Mark | See Remarks | Grant | 500.0K | $0.00 | $0 |
| 2026-02-27 | Gibson James R II | See Remarks | Grant | 333.8K | $0.00 | $0 |
| 2026-02-27 | HENRY CHRISTIAN O | See Remarks | Grant | 920.8K | $0.00 | $0 |
1–10 of 16
第 1 页 / 共 2 页